HOYA Vision Care Highlights Latest Evidence and Advances in Myopia Management at APOC 2023

Delhi – 5th June 2023 – HOYA Vision Care, a leader in optical technology innovation, was delighted to be an official gold sponsor at the 23rd Asia Pacific Optometric Congress (APOC 2023) that took place 2–4 June 2023 in Delhi, India. During the conference, HOYA hosted a leader in optical technology innovation, was delighted to be an official gold sponsor at the 23rd Asia Pacific Optometric Congress (APOC 2023) that took place 2–4 June 2023 in Delhi, India. During the conference, HOYA hosted the symposium, Lighting the way: new evidence and advances in myopia management, where leading experts shared the latest results from clinical studies on the DIMS spectacle lenses, and discussed the role of outdoor time and combination treatment in myopia management. Lastly the new additions to the MiYOSMART portfolio – MiYOSMART sun spectacle lenses were announced. the symposium, “Lighting the way: new evidence and advances in myopia management”, where leading experts shared the latest results from clinical studies on the DIMS spectacle lenses and discussed the role of outdoor time and combination treatment in myopia management. Lastly the new additions to the MiYOSMART portfolio – MiYOSMART sun spectacle lenses were announced. 

Professor Carly Lam, Professor of the School of Optometry at The Hong Kong Polytechnic University, presented the MiYOSMART six-year follow-up clinical study and real-world study. The findings of the six-year follow-up study showed that the MiYOSMART spectacle lens myopia control effect is sustained over six years for children wearing the lens and that children who stop wearing the MiYOSMART spectacle lens show no rebound effects.¹ 

A growing body of literature suggests that outdoor time and daylight are protective against myopia development and its progression in children.^2-6 Professor Dennis Tse, Associate Professor of the School of Optometry at The Hong Kong Polytechnic University, presented new evidence from epidemiological studies and animal studies that explain the biological mechanisms underlying the protective effect of outdoor time and daylight against myopia development and its progression, as well as explored the effects of high light intensity and optical defocus.  

Dr. Pavan Verkicharla, Scientist – Myopia Research Head, The Myopia Centre (prevention & control) at LV Prasad Eye Institute, India, highlighted the role of combination treatment strategies for controlling axial length growth – the recommended primary goal of the clinical trials for myopia management⁷– and discussed key considerations to achieve the desired treatment outcomes. 

Dr. May Zhang, Global Head of Professional Affairs at HOYA Vision Care, presented the new MiYOSMART sun solutions – MiYOSMART Chameleon, photochromic spectacle lenses; and MiYOSMART Sunbird, polarized spectacle lenses – which will be rolled out in 30 countries worldwide. These two new products provide protection from intense sunlight, while simultaneously slowing down myopia progression using the same D.I.M.S. Technology used in MiYOSMART clear spectacle lenses^8-14 shown to slow myopia progression on average by 60% in children aged 8 to 13.¹⁵  

''The partnership with APOC, is a great opportunity for HOYA Vision Care who continues to be committed in education and advances in myopia management. We are proud to announce to industry experts the new MiYOSMART sun solutions, together we can enable children across the world to spend more time outdoors without compromising their eyesight so that they can maximise the benefits of outdoor time and D.I.M.S. Technology on myopia management,” said Dr. May Zhang, Global Head of Professional Affairs at HOYA Vision Care. ''

Since its launch in 2018 until the end of 2022, over 4 million MiYOSMART spectacle lenses have been purchased by parents across the world.16 With the launch of MiYOSMART Chameleon and MiYOSMART Sunbird spectacle lenses, HOYA Vision Care will continue to help fight and control the growing problem of myopia around the world.  

For further information contact:

HOYA Vision Care PR

Susan Brown

susan@wearenomads.com

Follow HOYA Vision Care on Linkedin

Product Disclaimer: MiYOSMART spectacle lenses have not been approved for use in the management of Myopia in all countries, including the U.S., and are not currently available for sale in all countries, including the U.S.

References:

1. 1. Lam, C.S.Y., Tang, W.C., Zhang, H.Y. et al. Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years. Sci Rep 13, 5475 (2023). https://doi.org/10.1038/s41598-023-32700-7 

1. 2. Jonas JB, Ang M, Cho P, et al. IMI prevention of myopia and its progression. Invest Ophthalmol Vis Sci. 2021;62(5):6.  

1. 3. Ho CL, Wu WF, Liou YM. Dose-Response Relationship of Outdoor Exposure and Myopia Indicators: A Systematic Review and Meta-Analysis of Various Research Methods. Int J Environ Res Public Health. 2019;16(14):2595. 

1. 4. Xiong S, Sankaridurg P, Naduvilath T, et al. Time spent in outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic review. Acta Ophthalmol. 2017;95(6):551-566.  

1. 5. Dhakal R, Shah R, Huntjens B, et al. Time spent outdoors as an intervention for myopia prevention and control in children: an overview of systematic reviews. Ophthalmic Physiol Opt. 2022;42(3):545-558.  

1. 6. Karthikeyan SK, Ashwini DL, Priyanka M, et al. Physical activity, time spent outdoors, and near work in relation to myopia prevalence, incidence, and progression: An overview of systematic reviews and meta-analyses. Indian J Ophthalmol. 2022;70(3):728-739.  

1. 7. Wolffsohn JS, Kollbaum PS, Berntsen DA, et al. IMI – Clinical Myopia Control Trials and Instrumentation Report. Invest Ophthalmol Vis Sci. 2019;60:M132–M160. https:// doi.org/10.1167/iovs.18-25955 

1. 8. HOYA data on file. Transmission, traffic light recognition, and UV blocking test for MiYOSMART clear and polarized lenses. 02/2023. Tests were conducted at room temperature (23°C). 

1. 9. HOYA data on file. PSF test on MiYOSMART clear and sun spectacle lenses. 06/2022. 

1. 10. Lakkis C, Weidemann K. Evaluation of the performance of photochromic spectacle lenses in children and adolescents aged 10 to 15 years. Clin Exp Optom. 2006;89(4):246-252.  

1. 11. Renzi-Hammond LM, Hammond BR Jr. The effects of photochromic lenses on visual performance. Clin Exp Optom. 2016;99(6):568-574. 

1. 12. Wu PC, Kuo HK. Effect of photochromic spectacles on visual symptoms and contrast sensitivity of myopic schoolchildren treated with low dose concentration atropine. Invest Ophthalmol Vis Sci. 2016;57:2484. Available at: https://iovs.arvojournals.org/article.aspx?articleid=2560920 (Last accessed 01/06/2023). 

1. 13. WSPOS. Sunlight Exposure & Children’s Eyes Consensus Statement. 2016. Available at:  https://www.wspos.org/wspos-sunlight-exposure-childrens-eyes-consensus-statement/ (Last accessed 01/06/2023). 

1. 14. Quintana MS, Langa A, del Moral-Martinez I, et al. Polarized Filters Enhance Contrast Sensitivity When Glare Is Produced On A Flat Surface Under Photopic Conditions. Invest Ophthalmol Vis Sci. 2006;47(13):1225. 

1. 15. Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363-368. 

1. 16. Based on the number of MiYOSMART lenses sold as per Hoya sales data on file as of December 2022.